| commit | 1b7e9bdd53234cf9838afdf0b86c2753591eecaa | [log] [tgz] |
|---|---|---|
| author | Googler <pcloudy@google.com> | Wed Oct 18 02:09:21 2023 -0700 |
| committer | Copybara-Service <copybara-worker@google.com> | Wed Oct 18 02:10:36 2023 -0700 |
| tree | cb34af18af135f78d2f99b95696543083a53163e | |
| parent | 567aaf5f677b0d6939cf333f6eec2780c585764b [diff] |
Drop testing on ubuntu 1804 (JDK 11) and add testing on ubuntu 2204 (JDK 17) According to https://wiki.ubuntu.com/Releases, ubuntu 1804 did reach end of standard support in June 2023. Tests failure with JDK 17 resolved in: https://github.com/bazelbuild/bazel/issues/19850 Related https://github.com/bazelbuild/continuous-integration/issues/1757 PiperOrigin-RevId: 574407319 Change-Id: I97bb500a401c1f6fd4a37e4a52fee622f9d22225
{Fast, Correct} - Choose two
Build and test software of any size, quickly and reliably.
Speed up your builds and tests: Bazel rebuilds only what is necessary. With advanced local and distributed caching, optimized dependency analysis and parallel execution, you get fast and incremental builds.
One tool, multiple languages: Build and test Java, C++, Android, iOS, Go, and a wide variety of other language platforms. Bazel runs on Windows, macOS, and Linux.
Scalable: Bazel helps you scale your organization, codebase, and continuous integration solution. It handles codebases of any size, in multiple repositories or a huge monorepo.
Extensible to your needs: Easily add support for new languages and platforms with Bazel's familiar extension language. Share and re-use language rules written by the growing Bazel community.
Follow our tutorials:
To report a security issue, please email security@bazel.build with a description of the issue, the steps you took to create the issue, affected versions, and, if known, mitigations for the issue. Our vulnerability management team will respond within 3 working days of your email. If the issue is confirmed as a vulnerability, we will open a Security Advisory. This project follows a 90 day disclosure timeline.
See CONTRIBUTING.md
